HomeLedipasvir And SofosbuvirLedipasvir And Sofosbuvir + Doravirine Lamivudine And Tenofovir Disoproxil Fumarate

Does Ledipasvir And Sofosbuvir Interact with Doravirine Lamivudine And Tenofovir Disoproxil Fumarate?

Ledipasvir And Sofosbuvir and Doravirine Lamivudine And Tenofovir Disoproxil Fumarate have a moderate drug interaction according to U.S. FDA drug labeling data. Co-administration increases tenofovir plasma concentrations. Monitor for adverse reactions associated with tenofovir disoproxil fumarate. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ledipasvir And Sofosbuvir Class
Hepatitis C Virus NS5A Inhibitor
Doravirine Lamivudine And Tenofovir Disoproxil Fumarate Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Ledipasvir And Sofosbuvir and your doctor is considering prescribing Doravirine Lamivudine And Tenofovir Disoproxil Fumarate (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ledipasvir And Sofosbuvir(Harvoni)+💊 Doravirine Lamivudine And Tenofovir Disoproxil Fumarate(Delstrigo)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Hepatitis C Virus NS5A Inhibitor
Drug B class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Source
NLP:doravirine, lamivudine, and tenofovir disoproxil fumarate

What this means in plain English

Co-administration increases tenofovir plasma concentrations. Monitor for adverse reactions associated with tenofovir disoproxil fumarate.

About Ledipasvir And Sofosbuvir and Doravirine Lamivudine And Tenofovir Disoproxil Fumarate

Ledipasvir And Sofosbuvir is a Hepatitis C Virus NS5A Inhibitor, while Doravirine Lamivudine And Tenofovir Disoproxil Fumarate is a Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor. You may recognize them by the brand names Harvoni and Delstrigo. Both medications are taken by mouth. Both Ledipasvir And Sofosbuvir and Doravirine Lamivudine And Tenofovir Disoproxil Fumarate carry an FDA boxed warning — the agency's most serious safety designation.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ledipasvir And Sofosbuvir and Doravirine Lamivudine And Tenofovir Disoproxil Fumarate against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.